TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

Shitalkumar P Zambad, Davinder Tuli, Anoop Mathur, Sameer A Ghalsasi, Anita R Chaudhary, Shailesh Deshpande, Ramesh C Gupta, Vijay Chauthaiwale, Chaitanya DuttTorrent Research Centre, Torrent Pharmaceuticals Ltd, Gujarat, IndiaBackground: Patients with diabesity have a significantly increa...

Full description

Bibliographic Details
Main Authors: Zambad SP, Tuli D, Mathur A, Ghalsasi SA, Chaudhary AR, Deshpande S, Gupta RC, Chauthaiwale V, Dutt C
Format: Article
Language:English
Published: Dove Medical Press 2013-12-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Online Access:http://www.dovepress.com/trc210258-a-novel-tgr5-agonist-reduces-glycemic-and-dyslipidemic-cardi-a15350

Internet

http://www.dovepress.com/trc210258-a-novel-tgr5-agonist-reduces-glycemic-and-dyslipidemic-cardi-a15350

Similar Items